ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

XOMA XOMA Corporation

24.91
-0.17 (-0.68%)
May 24 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 6,406
Bid Price 14.42
Ask Price 30.00
News -
Day High 25.48

Low
13.48

52 Week Range

High
27.00

Day Low 24.4293
Share Name Share Symbol Market Stock Type
XOMA Corporation XOMA NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
-0.17 -0.68% 24.91 16:30:00
Open Price Low Price High Price Close Price Previous Close
25.10 24.4293 25.48 24.91 25.08
Trades Shares Traded VWAP Financial Volume Average Volume 52 Week Range
288 6,406 US$ 25.07 US$ 160,630 - 13.48 - 27.00
Last Trade Type Quantity Price Currency
15:02:01 priorref 186 US$ 24.91 USD

XOMA Corporation Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
294.13M 11.63M - 4.76M -40.83M -3.51 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

XOMA News

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No XOMA Message Board. Create One! See More Posts on XOMA Message Board See More Message Board Posts

Historical XOMA Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week25.9026.3224.2625.2213,615-0.99-3.82%
1 Month25.0826.73523.6925.2510,671-0.17-0.68%
3 Months24.2727.0023.0025.3015,0000.642.64%
6 Months15.7927.0014.3321.2821,5479.1257.76%
1 Year18.5027.0013.4818.6928,5846.4134.65%
3 Years31.6939.0213.4821.2129,721-6.78-21.39%
5 Years17.8146.3213.4823.4338,5627.1039.87%

XOMA Description

XOMA Corp is a biotechnology royalty aggregator playing a unique role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceutical or biotechnology companies. When XOMA acquires future economic rights, the seller receives non-dilutive, non-recourse funding that can use to advance their internal drug candidate(s) or for general corporate purposes.

Your Recent History

Delayed Upgrade Clock